degenerative eye disease

A new study suggests that DNA synthesized in the cell cytoplasm drives retinal cell death in an advanced form of age-related macular degeneration, a leading cause of blindness.

Imaged in real time in living people, immune cells at the surface of the retina could serve as biomarkers to detect retinal and possibly neurological diseases and track their progression.

For the first time, a transplant of replacement tissue grown from stem cells has been shown to be feasible for patients with macular degeneration.

Researchers discover a genetic link in mice between thinner corneas and an increased risk of developing glaucoma.

Using the latest technologies, researchers are constructing novel prosthetic devices to restore vision in the blind.

Synthetic yeast chromosome; human enhancers and promoters mapped; brain-wide map links fly behaviors to neurons; treating eye diseases with nanotechnology

Nanotechnology could transform the way clinicians treat eye diseases.

In blind mice, a light-stimulated small molecule temporarily confers photosensitivity to retinal ganglion cells despite rod and cone damage.

Directed evolution of a gene therapy virus vector improves its penetration into the retina.

A strategy to transmit signals to retinal nerve cells may show promise as a step toward alternative retinal prosthesis design.